[1]刘洪波,祁晓莉,乔 星,等.HPV分型检测联合TCT检查在宫颈病变筛查中的应用[J].医学信息,2018,31(08):152-153,156.[doi:10.3969/j.issn.1006-1959.2018.08.053]
　LIU Hong-bo,QI Xiao-li,QIAO Xing,et al.Application of HPV Typing Test Combined with TCT Examination in Screening Cervical Lesions[J].Journal of Medical Information,2018,31(08):152-153,156.[doi:10.3969/j.issn.1006-1959.2018.08.053]
点击复制

HPV分型检测联合TCT检查在宫颈病变筛查中的应用()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年08期
页码:
152-153,156
栏目:
诊疗技术
出版日期:
2018-04-15

文章信息/Info

Title:
Application of HPV Typing Test Combined with TCT Examination in Screening Cervical Lesions
文章编号:
1006-1959（2018）08-0152-03
作者:
刘洪波; 祁晓莉; 乔 星; 杜 睿; 王丽梅
北京市大兴区人民医院病理科，北京 102600
Author(s):
LIU Hong-bo; QI Xiao-li; QIAO Xing; DU Rui; WANG Li-mei
Department of Pathology,People's Hospital,Daxing District,Beijing 102600,China
关键词:
HPV; TCT; 联合检测; 宫颈病变筛查
Keywords:
Key words：HPV; TCT; Combined detection; Cervical lesion screening
分类号:
R737.33
DOI:
10.3969/j.issn.1006-1959.2018.08.053
文献标志码:
B
摘要:
目的 探究人乳头瘤病毒（HPV）以及液基细胞学（TCT）的联合检测在宫颈病变的筛查中的应用。方法 选取2015 年12月~2016年11月因宫颈异常来我院就诊的2327例妇科疾病患者，对其实施TCT以及HPV DNA检测，对阳性的患者进行阴道镜活检，以患者组织的病理学结果作为最终确诊标准。结果 共计355例患者进行阴道镜检查，其中HPV检测灵敏度为75.72%，准确性为70.43%，特异性为30.22%；TCT检测灵敏度为41.32%，准确性43.40%，特异性为47.87%；二者联合诊断灵敏度为88.21%，准确率75.10%，特异性为43.36%。两种检测方法的阳性检出敏感度相比，差异有统计学意义（P＜0.05）。结论 HPV分型检测联合TCT的检测方式具有相当高的阳性率及灵敏度，能够提高患者宫颈病变的检出率，延长患者的筛查间隔，有利于临床上对于宫颈病变的筛查。
Abstract:
Abstract：Objective To investigate the application of combined detection of human papillomavirus(HPV)and liquid-based cytology (TCT)in the screening of cervical lesions.Methods From December 2015 to November 2016,2327 patients with gynecological diseases who were diagnosed by cervical abnormality were examined by TCT and HPV DNA,and the positive patients were examined by colposcopy.Pathological findings of the patient's tissues were used as the final diagnostic criteria.Results A total of 355 patients were examined with colposcopy,in which the sensitivity of HPV was 75.72%,the accuracy was 70.43%,the specificity was 30.22%,the sensitivity of TCT was 41.32%,the accuracy was 43.40%,and the specificity was 47.87%;the sensitivity of the combined diagnosis was 88.21%,the accuracy rate was 75.10%,and the specificity was 43.36%.The sensitivity of the two detection methods was statistically significant(P<0.05).Conclusion The detection method of HPV typing combined with TCT has a high positive rate and sensitivity, which can improve the detection rate of the cervical lesions and prolong the screening interval of the patients,which is beneficial to the screening of cervical lesions.

参考文献/References:

[1]张玉新,李维强,陈拉妮,等.HPV感染与宫颈病变相关性的初步研究[J].中国医药指南,2010,8(30):177-179.
[2]白鹏来,宋伟奇,梁英,等.内蒙古东部地区2005-2010年宫颈癌及宫颈上皮内瘤变的机会性筛查研究[J].内蒙古医学杂志,2011,43(5):519-523.
[3]吴兵,李铭芬,张崇移,等.人乳头瘤病毒与与宫颈病变的相关性研究[J].中华医药感染学杂志,2013,10(23):2377-2379.
[4]李玉霞,张燕.高危型HPV筛查联合液基细胞学检测在宫颈癌筛检中的应用价值[J].海南医学院学报,2014,20(2):223-225.
[5]陈铭,李娟,尹格平,等.多种I-IPV亚型检测在宫颈病变诊治中的意义[J].中国现代妇幼保健,2012,27(2):195-198.
[6]张丽娜,周蓓蓓,张玢,等.HR-HPV检测与细胞学联合检查在宫颈病变筛查中的应用[J].中国现代医学杂志,2011,21(14):1665-1669.

相似文献/References:

[1]聂小凤,翟慧慧,冷天艳,等.宫颈脱落细胞miR34a检测在HR-HPV阳性患者 分流中的作用分析[J].医学信息,2018,31(16):43.[doi:10.3969/j.issn.1006-1959.2018.16.012]
　NIE Xiao-feng,ZHAI Hui-hui,LENG Tian-yan,et al.Analysis of the Role of MiR34a in Cervical Exfoliated Cells in Shunt of HR-HPV Positive Patients[J].Journal of Medical Information,2018,31(08):43.[doi:10.3969/j.issn.1006-1959.2018.16.012]
[2]邬素珍,许焕英.宫颈人乳头瘤病毒感染的免疫研究进展[J].医学信息,2018,31(19):33.[doi:10.3969/j.issn.1006-1959.2018.19.012]
　WU Su-zhen,XU Huan-ying.Progress in Immunization of Cervical Human Papillomavirus Infection[J].Journal of Medical Information,2018,31(08):33.[doi:10.3969/j.issn.1006-1959.2018.19.012]
[3]刘琳琳,宫 正,杨海嵘,等.宫颈癌的诊治及预防研究[J].医学信息,2021,34(03):49.[doi:10.3969/j.issn.1006-1959.2021.03.015]
　LIU Lin-lin,GONG Zheng,YANG Hai-rong,et al.Research on Diagnosis,Treatment and Prevention of Cervical Cancer[J].Journal of Medical Information,2021,34(08):49.[doi:10.3969/j.issn.1006-1959.2021.03.015]
[4]祝亚军.高危型HPV-DNA及TCT检测筛查宫颈癌及宫颈癌前病变的价值[J].医学信息,2019,32(22):157.[doi:10.3969/j.issn.1006-1959.2019.22.054]
　ZHU Ya-jun.The Value of Screening High-Risk HPV-DNA and TCT for Cervical Carcinoma and Cervical Precancerous Lesions[J].Journal of Medical Information,2019,32(08):157.[doi:10.3969/j.issn.1006-1959.2019.22.054]
[5]朱 军,张振君.妇女宫颈病变筛查分析[J].医学信息,2019,32(01):139.[doi:10.3969/j.issn.1006-1959.2019.01.043]
　ZHU Jun,ZHANG Zhen-jun.Screening Analysis of Cervical Lesions in Women[J].Journal of Medical Information,2019,32(08):139.[doi:10.3969/j.issn.1006-1959.2019.01.043]
[6]邵景萍.HPV联合TCT检测在宫颈疾病筛查中的应用[J].医学信息,2022,35(10):168.[doi:10.3969/j.issn.1006-1959.2022.10.043]
　SHAO Jing-ping.Application of HPV Combined with TCT in Cervical Disease Screening[J].Journal of Medical Information,2022,35(08):168.[doi:10.3969/j.issn.1006-1959.2022.10.043]
[7]李明明,赵 芳,张亚青.TCT、HPV联合阴道镜检测在早期宫颈癌及癌前病变筛查中的应用价值[J].医学信息,2023,36(13):103.[doi:10.3969/j.issn.1006-1959.2023.13.020]
　LI Ming-ming,ZHAO Fang,ZHANG Ya-qing.Application Value of TCT, HPV Combined with Colposcopy in the Screening of Early-stage Cervical Cancer and Precancerous Lesions[J].Journal of Medical Information,2023,36(08):103.[doi:10.3969/j.issn.1006-1959.2023.13.020]
[8]见永康,吴泽俊,庄雅丽.宫颈癌筛查联合阴道镜活检防治宫颈癌前病变的价值研究[J].医学信息,2023,36(16):117.[doi:10.3969/j.issn.1006-1959.2023.16.022]
　JIAN Yong-kang,WU Ze-jun,ZHUANG Ya-li.Study on the Value of Cervical Cancer Screening Combined with Colposcopy Biopsy in the Prevention and Treatment of Cervical Precancerous Lesions[J].Journal of Medical Information,2023,36(08):117.[doi:10.3969/j.issn.1006-1959.2023.16.022]

更新日期/Last Update: 2018-04-15